CELL WORKS INC has a total of 16 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are RADEMACHER GROUP LTD, TERCICA INC and HORIZON THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United Kingdom | 1 | |
#7 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Ts O Paul O P | 11 |
#2 | Wang Zheng-Pin | 7 |
#3 | Deamond Scott | 7 |
#4 | Duff Robert | 7 |
#5 | Lesko Stephen A | 5 |
#6 | Paul O P Ts O | 4 |
#7 | Zhou Yuanzhong | 3 |
#8 | Roby Clinton | 3 |
#9 | Robert Duff | 1 |
#10 | Clinton Roby | 1 |
Publication | Filing date | Title |
---|---|---|
AU2002365420A1 | Ligands to enhance cellular uptake of biomolecules | |
AU1798002A | Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use | |
AU2876900A | Class characterization of circulating cancer cells isolated from body fluids andmethods of use | |
CA2350692A1 | Multiple marker characterization of single cells |